polycystic ovary syndrome. Sclerocystic ovary syndrome Stein-Leventhal syndrome
Conditions
Interventions
Intervention 1: intervention:capsules of fish-oil (3 g/d) for 2 month. Intervention 2: placebos of fish-oil (3 g/d) for 2 month.
Placebo
intervention:capsules of fish-oil (3 g/d) for 2 month
placebos of fish-oil (3 g/d) for 2 month
Sponsors
Institute for Reproductive Sciences, Research and clinical Center for Infertility
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: criteria inclusion: females 20-40years; PCOS diagnostic according to Roterdam criteria; BMI>25; No history about intake of any drug during the last 3 months that may affect the insulin sensitivity or hormonal profile such as: oral contraceptives, glucocorticoids, ovulation induction agents, anti diabetic and anti obesity drugs, estrogenic, antiandrogenic or anti hypertensive medication; Not being in any diet in the last 3month; Do not have any addiction to tobacco and alcohol; Do not taking a Omega-3 supplement in the last 3 month; Do not be menopause; Do not use anti-coagulant medicine; Do not use anti-depression medication; Do not be diabetic and hypothyroidism. exclusion criteria: Essentially needs for intake of OCP to treatment; Do not will to be in the study; Do not obey the Protocols of the study and do not digest more than 20% of supplements.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum visfatin-. Timepoint: before and after intervention. Method of measurement: visfatin ng/ml Elisa kit-.;Serum adiponectin. Timepoint: before and after intervention. Method of measurement: adiponectin Elisa kit µg/ml-.;Serum LH. Timepoint: before and after intervention. Method of measurement: LH Elisa kit U/l.;Serum FSH. Timepoint: before and after intervention. Method of measurement: FSHElisa kit U/l-.;Serum Prolactin. Timepoint: before and after intervention. Method of measurement: prolactin Elisa ng/mL.;Body weight. Timepoint: before and after intervention. Method of measurement: leveled platform scale.;BMI-. Timepoint: before and after intervention. Method of measurement: leveled platform scale-stadiometer.;Waist circumference. Timepoint: before and after intervention. Method of measurement: tape.;Hip circumference. Timepoint: before and after intervention. Method of measurement: tape. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHoorieh Daneshbodi
Shahid sadoughi university of medical sciences and health services
Outcome results
None listed